Goldman Sachs Group Inc Entrada Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 84,466 shares of TRDA stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,466
Previous 33,302 153.64%
Holding current value
$1.49 Million
Previous $474,000 184.81%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$13.65 - $17.86 $698,388 - $913,789
51,164 Added 153.64%
84,466 $1.35 Million
Q2 2024

Aug 13, 2024
BUY
$11.85 - $16.45 $189,351 - $262,854
15,979 Added 92.24%
33,302 $474,000
Q1 2024

May 15, 2024
SELL
$11.58 - $17.0 $8,580 - $12,597
-741 Reduced 4.1%
17,323 $245,000
Q4 2023

Feb 13, 2024
BUY
$11.36 - $16.99 $59,753 - $89,367
5,260 Added 41.08%
18,064 $272,000
Q3 2023

May 14, 2024
SELL
$13.61 - $18.01 $71,588 - $94,732
-5,260 Reduced 29.12%
12,804 $202,000
Q3 2023

Nov 14, 2023
SELL
$13.61 - $18.01 $116,120 - $153,661
-8,532 Reduced 39.99%
12,804 $202,000
Q2 2023

May 14, 2024
SELL
$11.02 - $18.01 $284,756 - $465,378
-25,840 Reduced 54.77%
21,336 $323,000
Q2 2023

Aug 14, 2023
SELL
$11.02 - $18.01 $284,756 - $465,378
-25,840 Reduced 54.77%
21,336 $323,000
Q1 2023

May 14, 2024
SELL
$9.58 - $16.2 $3.4 Million - $5.75 Million
-354,863 Reduced 88.27%
47,176 $684,000
Q1 2023

May 11, 2023
SELL
$9.58 - $16.2 $3.4 Million - $5.75 Million
-354,863 Reduced 88.27%
47,176 $684,000
Q4 2022

May 14, 2024
SELL
$13.52 - $22.89 $648,338 - $1.1 Million
-47,954 Reduced 10.66%
402,039 $5.44 Million
Q4 2022

Feb 13, 2023
SELL
$13.52 - $22.89 $648,338 - $1.1 Million
-47,954 Reduced 10.66%
402,039 $5.44 Million
Q3 2022

May 14, 2024
BUY
$9.65 - $15.76 $41,562 - $67,878
4,307 Added 0.97%
449,993 $7.09 Million
Q3 2022

Nov 10, 2022
BUY
$9.65 - $15.76 $41,562 - $67,878
4,307 Added 0.97%
449,993 $7.09 Million
Q2 2022

May 14, 2024
BUY
$5.49 - $12.94 $2.35 Million - $5.53 Million
427,622 Added 2367.26%
445,686 $5.43 Million
Q2 2022

Aug 15, 2022
BUY
$5.49 - $12.94 $1,268 - $2,989
231 Added 0.05%
445,686 $5.43 Million
Q4 2021

Feb 17, 2022
SELL
$13.7 - $35.0 $98.4 Million - $251 Million
-7,180,727 Reduced 94.16%
445,455 $7.63 Million
Q4 2021

Feb 14, 2022
BUY
$13.7 - $35.0 $104 Million - $267 Million
7,626,182 New
7,626,182 $131 Million

Others Institutions Holding TRDA

# of Institutions
101
Shares Held
28.1M
Call Options Held
34.5K
Put Options Held
16.4K
View Full List

About Entrada Therapeutics, Inc.

TRDA Quotes by TradingView
  • Ticker TRDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,368,500
  • Market Cap $552M
  • Description
  • Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...
More about TRDA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email